New regimen for interpleural block in children

Area of Science:

• Anesthesiology
• Pediatric Surgery
• Pharmacology

Background:

• Effective postoperative pain management is crucial for recovery after thoracic surgery in children.
• Traditional analgesia methods may have limitations in providing sustained pain relief.
• Interpleural regional anesthesia offers a targeted approach to thoracic pain control.

Purpose of the Study:

• To evaluate the safety and efficacy of a novel interpleural bupivacaine infusion regimen for postoperative analgesia in children undergoing thoracic surgery.
• To assess plasma and pleural bupivacaine levels to determine pharmacokinetic profiles and potential toxicity.

Main Methods:

• Eight pediatric patients received continuous interpleural infusion of 0.1% bupivacaine.
• Infusion rates were adjusted (0.5–1 ml.kg-1.h-1) for 48 hours based on pain scores.
• Plasma bupivacaine and metabolite (PPX) levels were measured at 24 and 48 hours.
• Pleural bupivacaine levels and orosomucoid (bupivacaine binding protein) were assessed in select patients.

Main Results:

• The proposed interpleural bupivacaine regimen demonstrated safety in pediatric patients for 48 hours.
• Pain scores guided the titration of the bupivacaine infusion, indicating effective analgesia.
• Measured plasma bupivacaine levels remained within acceptable safety ranges throughout the study period.

Conclusions:

• This interpleural bupivacaine infusion regimen is a safe and effective option for postoperative analgesia following pediatric thoracic surgery.
• The study supports the use of this method for sustained pain management, contributing to improved patient outcomes.